Literature DB >> 15576935

Methods for preparation of proteins and protein complexes that regulate the eukaryotic cell cycle for structural studies.

Julie Welburn1, Jane Endicott.   

Abstract

The determination of structures for proteins that control the eukaryotic cell cycle by nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography has made a significant contribution to our understanding of the molecular mechanisms that control cell cycle progression. CDK2 has proved particularly tractable to structural analysis, and CDK2 in complex with various regulatory proteins and in different phosphorylation states provides a paradigm for the control of this important kinase family. This chapter describes a number of protocols that can be used to prepare CDKs and selected CDK binding proteins suitable for structural studies by heterologous expression in either E. coli or insect cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15576935     DOI: 10.1385/1-59259-857-9:219

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Arabidopsis PASTICCINO2 is an antiphosphatase involved in regulation of cyclin-dependent kinase A.

Authors:  Marco Da Costa; Liên Bach; Isabelle Landrieu; Yannick Bellec; Olivier Catrice; Spencer Brown; Lieven De Veylder; Guy Lippens; Dirk Inzé; Jean-Denis Faure
Journal:  Plant Cell       Date:  2006-05-12       Impact factor: 11.277

2.  Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.

Authors:  Isabelle Landrieu; Caroline Smet-Nocca; Laziza Amniai; Justin Vijay Louis; Jean-Michel Wieruszeski; Jozef Goris; Veerle Janssens; Guy Lippens
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

3.  CDK1 structures reveal conserved and unique features of the essential cell cycle CDK.

Authors:  Nicholas R Brown; Svitlana Korolchuk; Mathew P Martin; Will A Stanley; Rouslan Moukhametzianov; Martin E M Noble; Jane A Endicott
Journal:  Nat Commun       Date:  2015-04-13       Impact factor: 14.919

4.  Amyloid β1-42 (Aβ1-42) Induces the CDK2-Mediated Phosphorylation of Tau through the Activation of the mTORC1 Signaling Pathway While Promoting Neuronal Cell Death.

Authors:  Ki Hoon Lee; Sei-Jung Lee; Hyun Jik Lee; Gee Euhn Choi; Young Hyun Jung; Dah Ihm Kim; Amr Ahmed Gabr; Jung Min Ryu; Ho Jae Han
Journal:  Front Mol Neurosci       Date:  2017-07-24       Impact factor: 5.639

5.  BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation.

Authors:  Maxime Sartori; Tiago Mendes; Shruti Desai; Alessia Lasorsa; Adrien Herledan; Nicolas Malmanche; Petra Mäkinen; Mikael Marttinen; Idir Malki; Julien Chapuis; Amandine Flaig; Anaïs-Camille Vreulx; Marion Ciancia; Philippe Amouyel; Florence Leroux; Benoit Déprez; François-Xavier Cantrelle; Damien Maréchal; Laurent Pradier; Mikko Hiltunen; Isabelle Landrieu; Devrim Kilinc; Yann Herault; Jocelyn Laporte; Jean-Charles Lambert
Journal:  Acta Neuropathol       Date:  2019-05-07       Impact factor: 17.088

6.  Highly disordered histone H1-DNA model complexes and their condensates.

Authors:  Abigail L Turner; Matthew Watson; Oscar G Wilkins; Laura Cato; Andrew Travers; Jean O Thomas; Katherine Stott
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

7.  Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates.

Authors:  François-Xavier Cantrelle; Anne Loyens; Xavier Trivelli; Oliver Reimann; Clément Despres; Neha S Gandhi; Christian P R Hackenberger; Isabelle Landrieu; Caroline Smet-Nocca
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

8.  Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation.

Authors:  Alessia Lasorsa; Idir Malki; François-Xavier Cantrelle; Hamida Merzougui; Emmanuelle Boll; Jean-Charles Lambert; Isabelle Landrieu
Journal:  Front Mol Neurosci       Date:  2018-11-14       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.